23:25:00 EDT Tue 19 May 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Diagnos Inc (3)
Symbol ADK
Shares Issued 120,412,549
Close 2026-05-19 C$ 0.20
Market Cap C$ 24,082,510
Recent Sedar+ Documents

Diagnos convertible debenture amendment

2026-05-19 21:31 ET - Private Placement - Debenture

Further to the TSX Venture Exchange bulletins dated May 26, 2023, and May 26, 2025, the exchange has accepted for filing a debenture amendment as announced on May 13, 2026.

Financing type:  non-brokered private placement

Original offering:  $865,000 principal amount of convertible debentures, convertible into 2,337,837 listed shares

Remaining amended offering:  $300,000 principal amount of convertible debentures, convertible into 810,810 listed shares

Conversion price:  37 cents per listed share

Original maturity date:  May 18, 2025, as modified to May 18, 2026

Amended maturity date:  May 18, 2027

Interest rate:  10 per cent per annum

The convertible debentures in the principal amount of $865,000 were issued pursuant to a non-brokered private placement, which was originally announced on May 18, 2023, and accepted for filing by the exchange effective May 26, 2023. The amendment to maturity date from May 18, 2025, to May 18, 2026, was announced on May 20, 2025, and accepted for filing by the exchange effective May 26, 2025.

For further information, please refer to the company's news releases dated May 18, 2023, May 20, 2025, and May 13, 2026.

© 2026 Canjex Publishing Ltd. All rights reserved.